Get started
LGALS3

Heavy insider buying here

Long
Galectin Therapeutics Inc. (NASDAQ:GALT)  
LGALS3  
NASDAQ:GALT   Galectin Therapeutics Inc.
Fundamental Analysis Growth Beyond Technical Analysis
2
0
fundamental growth beyondta
Several insider buys from board of directors members in recent days.

CEO takes 80% pay in shares.

The multi-billionaire chairman added $40 million stake in past couple years.

Also, there is strong support at this price level.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.